Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
$ZBIO Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $4.54 per share, missing analysts’ estimates. The company did ...
Thursday, August 6, 2026
Tag: biopharma
-1024x683.jpg "The Key Battles for Senate Control Are Set")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.